Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Safety Study of Combination Treatment With Avonex and Zocor in Relapsing Remitting Multiple Sclerosis

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2005 by Alabama Neurology Associates, PC.
Recruitment status was:  Recruiting
Sponsor:
Collaborator:
Biogen
Information provided by:
Alabama Neurology Associates, PC
ClinicalTrials.gov Identifier:
NCT00242268
First received: October 19, 2005
Last updated: December 6, 2005
Last verified: September 2005
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given